TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
Back to search
Official data from USPTO
ASTER INSIGHTS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ASTER INSIGHTS
ST13
US500000097849603Class
42, 44
Filing
97849603
Registration
7739987
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
11/16/2025
Trademark type
Word
Nice classes
42, 44
Filing date
03/21/2023
Registration date
03/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/25/2025
Last transaction
11/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/14/2023
First use in commerce
04/14/2023
Drawing code
4
Owner type
03
Owner location
Hudson, FL
Examiner
WEIGLE,KATHERINE CONNOLLY
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M2Gen, Corp.
Representatives
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing an electronic database for the collection and storage of clinical and molecular data derived from a patientan electronic database featuring medical and scientific research information in the field of human clinical and molecular data analysis for aiding medical diagnosticsdiscovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; medical and scientific research data analysis and bioinformatics consulting services relating theretocomputer software consultingproviding online non-downloadable computer software platforms for analyzing medical and scientific research datascientific research data analytics consulting in connection with an electronic database for the collection and storage of medical and scientific research information in the fields of clinical and molecular data accumulated for aiding medical diagnosticdiscovery and development and prognostics and evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; providing an Internet-accessible website portal featuring medical records for use by physicianspatients and researchers for the storage and accessibility of electronic medical research data in the field of human clinical and molecular data and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness; providing consulting services relating thereto for the aforementioned services
Class 44
Providing an electronic database for the collection and storage of clinical and molecular data derived from a patientan electronic database featuring medical information in the field of human clinical and molecular data analysis for aiding medical diagnosticsdiscovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; Health care servicesproviding a database in the field of cancer and other disease medical information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Providing a database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectivenessproviding medical information data regarding tumor-specific molecular signaturesproviding objective medical information data on the effectiveness of a drug and/or diagnostic testproviding evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes; collection and analysis of data services in the field of human clinical and molecular data for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseasesmedical services in the nature of matching particular patients to a particular drugtreatmenttherapy or clinical trial by the specific molecular signature of the patient; providing an Internet-accessible website portal featuring medical records for use by physicianspatients and researchers for the storage and accessibility of electronic medical information data in the field of human clinical and molecular data and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness; providing consulting services relating thereto for the aforementioned services.
Publications
History of USPTO decisions and trademark events.
34 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/25/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/28/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/28/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/22/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/22/2025
IUAF
USE AMENDMENT FILED
12/11/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/11/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/18/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2024
PUBO
PUBLISHED FOR OPPOSITION
04/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/21/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/21/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/21/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/21/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/28/2024
GNRT
NON-FINAL ACTION E-MAILED
02/28/2024
CNRT
NON-FINAL ACTION WRITTEN
02/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/19/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/18/2023
GNRT
NON-FINAL ACTION E-MAILED
12/18/2023
CNRT
NON-FINAL ACTION WRITTEN
12/18/2023
DOCK
ASSIGNED TO EXAMINER
12/15/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2023
NWAP
NEW APPLICATION ENTERED
03/24/2023
Continuous trademark protection
Get notified about every new filing that threatens ASTER INSIGHTS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.